TY  - GEN
AU  - Fosså,Alexander
AU  - Smeland,Knut
AU  - Fagerli,Unn-Merete
AU  - Galleberg,Renate B
AU  - Bersvendsen,Hanne S
AU  - Holte,Harald
TI  - Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016
SN  - 1651-226X
PY  - 2020///0622
KW  - Adult
KW  - Allografts
KW  - Antineoplastic Agents, Immunological
KW  - therapeutic use
KW  - Brentuximab Vedotin
KW  - Female
KW  - Hodgkin Disease
KW  - mortality
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Norway
KW  - Recurrence
KW  - Stem Cell Transplantation
KW  - Survival Analysis
KW  - Transplantation, Autologous
KW  - Treatment Outcome
N1  - Publication Type: Letter; Multicenter Study
UR  - https://doi.org/10.1080/0284186X.2019.1652765
ER  -